Mangaceuticals, Inc. 8-K Report: Key Developments on February 14, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

1. Company Information:

• Name: Mangaceuticals, Inc.
• State of Incorporation: Texas (TX)
• Address: 15110 N. Dallas Parkway, Suite 600, Dallas, TX 75248
• Phone Number: (214) 242-9619
• CIK (Central Index Key): 0001938046

2. SEC Filing Details:

• Form Type: 8-K
• Filing Date: February 14, 2025
• SEC File Number: 001-41615
• IRS Employer Identification Number: 87-3841292

3. Financial Information:

• Common Stock: $0.0001 par value per share
• Ticker Symbol: MGRX (traded on NASDAQ)

4. Reporting Context:

• Reporting Period: The report covers a single day, February 14, 2025.
• Currency: USD (United States Dollar)
• Measurement Units: The report mentions shares and USD per share.

5. Miscellaneous:

• The XBRL instance references are noted, indicating this is part of a structured data format for financial reporting.

Insights:

• The filing is a Form 8-K, which typically reports unscheduled material events or corporate changes, indicating that the information may pertain to significant developments within Mangaceuticals, Inc. around the specified date.
• The company is publicly traded, and the choice of NASDAQ suggests a possibly higher profile and regulatory scrutiny.
• The low par value of the common stock ($0.0001) may indicate a startup or growth stage company, potentially appealing to investors looking for high-risk, high-reward opportunities.

Overall, this report is essential for stakeholders looking to assess recent developments in Mangaceuticals, Inc., particularly in terms of corporate governance and financial performance on the date indicated.